Azopharma Report on OBJ Patch., page-32

Here is the problem right now, and why there is bashing. The positive on OBJ are vastly outnumbered by those which are negative on OBJ. The optimists are the minority. All signs say "no" for OBJs future market prospects.

This is very simply because OBJ has not produced results for a decade, is not producing results now, and isnt looking great to produce results in the future, despite its yearly mountain of promise.

Ive rung and emailed management multiple times over the years. The conversations are the same predictable outcome each time. Positive conversation which in hindsight is spin that goes no where.

Every year the market is told "this is our year","better position than ever","not long now".

For the wider market, it just sees OBJ as a cycle of spin doctors playing with magnets, a handful of gimmick products and a cash negative company asking for handouts for overpaid directors. Not all true, but the market couldn't care less.

Thats why we are knocking on the 1c door down from the high of 10c. The tolerance for promise is over, no one gives a sh#t about more fluff and stuff announcements. People want results without a side of BS. But instead, 2019,2020 and 2021 look like its more sh#te and promise.

Untill OBJ "show us the money" this will be a joke and deadweight stock.